Ziegler Capital Management, LLC Gilead Sciences, Inc. Transaction History

Ziegler Capital Management, LLC

$2.84 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$73.27 - $83.09 $49,677 - $56,335	-678 Reduced 2.81%	23,411 $1.9 Million
Q3 2023 Oct 16, 2023	SELL	$73.94 - $80.67 $139,524 - $152,224	-1,887 Reduced 7.26%	24,089 $1.81 Million
Q2 2023 Jul 25, 2023	BUY	$76.01 - $86.7 $10,717 - $12,224	141 Added 0.55%	25,976 $2 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $83,340 - $94,950	1,078 Added 4.35%	25,835 $2.14 Million
Q4 2022 Jan 24, 2023	SELL	$62.32 - $89.47 $3,302 - $4,741	-53 Reduced 0.21%	24,757 $0
Q3 2022 Oct 25, 2022	SELL	$59.54 - $68.01 $249,829 - $285,369	-4,196 Reduced 14.47%	24,810 $1.55 Million
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $70,937 - $79,897	1,229 Added 4.42%	29,006 $1.79 Million
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $544,332 - $682,106	-9,398 Reduced 25.28%	27,777 $1.67 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $264,840 - $300,598	4,082 Added 12.33%	37,175 $2.7 Million
Q3 2021 Oct 27, 2021	BUY	$67.69 - $73.03 $1.53 Million - $1.65 Million	22,611 Added 215.71%	33,093 $2.31 Million
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $52,108 - $56,936	-821 Reduced 7.26%	10,482 $722,000
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $2.86 Million - $3.26 Million	-47,589 Reduced 80.81%	11,303 $731,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $1.44 Million - $1.64 Million	-25,430 Reduced 30.16%	58,892 $3.43 Million
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $109,171 - $137,264	1,758 Added 2.13%	84,322 $5.33 Million
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $7.17 Million - $8.32 Million	-99,091 Reduced 54.55%	82,564 $6.35 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $11.4 Million - $14.6 Million	181,655 New	181,655 $13.6 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.

Account